Immunology Activities
New and Emerging Management Strategies for Acute Graft-Versus-Host Disease in Hematopoietic Stem Cell Transplant
0290-0000-21-026-H01-P
This activity will review clinical data for new and emerging strategies in aGVHD prevention and treatment, the role of biomarkers, and the role of the pharmacist in patient care.
1.50
Managing Chronic Immune Thrombocytopenia: Opportunities for Oncology Pharmacists to Optimize Patient Care
0290-0000-20-315-H01-P
This CE article will examine the epidemiology, pathophysiology, diagnosis, and impact of chronic immune thrombocytopenia (ITP) among patients with cancer.
2.00
Biosimilars: A Managed Care Update of Real-World Evidence and Cost-Savings Data When Treating Inflammatory Conditions
0290-0000-20-298-H01-P
This activity will identify the patient populations with rheumatic and inflammatory disease and consider the biologic costs associated with pharmacologic treatment.
1.00
Ankylosing Spondylitis: Targeting Interleukin Pathways for Early and Aggressive Disease Management
0290-0000-20-285-H01-P
This activity will explore the role of the interleukin pathway in ankylosing spondylitis (AS) and the need for early and aggressive disease management.
1.00